| Literature DB >> 31518386 |
Angela McCann1,2, Ian B Jeffery1,2, Bouchra Ouliass3, Guylaine Ferland3, Xueyen Fu4, Sarah L Booth4, Tam T T Tran1,2, Paul W O'Toole1,2, Eibhlís M O'Connor2,5,6.
Abstract
BACKGROUND: Vitamin K has multiple important physiological roles, including blood coagulation and beneficial effects on myelin integrity in the brain. Some intestinal microbes possess the genes to produce vitamin K in the form of menaquinone (MK). MK appears in higher concentration in tissues, such as the brain, particularly MK4, than the dietary form of phylloquinone (PK). Lower PK concentrations have been reported in patients with Alzheimer disease while higher serum PK concentrations have been positively associated with verbal episodic memory. Despite knowledge of the importance of vitamin K for various health parameters, few studies have measured MK concentration and biosynthesis by gut commensals.Entities:
Keywords: cognition; elderly; microbial menaquinone biosynthesis; shotgun metagenomic sequencing; vitamin K
Year: 2019 PMID: 31518386 PMCID: PMC6885478 DOI: 10.1093/ajcn/nqz220
Source DB: PubMed Journal: Am J Clin Nutr ISSN: 0002-9165 Impact factor: 7.045
Descriptive characteristics of the study participants[1]
| Characteristic | Mean ± SD | SEM |
|---|---|---|
| MMSE score | 24 ± 6.6 | 0.77 |
| Age, y | 78 ± 8.7 | 1.02 |
| Barthel score | 15.7 ± 6.3 | 0.74 |
| No. of hypertension medications | 0.4 ± 0.8 | 0.09 |
| No. of diabetes medications | 0.1 ± 0.4 | 0.04 |
| No. of diagnoses | 3.2 ± 2.3 | 0.27 |
| No. of drugs | 5.0 ± 3.0 | 0.36 |
| PK blood serum concentrations, nmol/L | 0.9 ± 1.1 | 0.13 |
| TNF-α, IU | 6.7 ± 6.9 | 0.82 |
| IL-6, IU | 14.9 ± 33.2 | 3.95 |
| IL-8, IU | 19.3 ± 18.8 | 2.24 |
| Diversity: Shannon index | 3.6 ± 0.5 | 0.06 |
| BMI, kg/m2 | 26.9 ± 6.3 | 0.73 |
Values are means ± SD and SEM for n = 74 elderly samples; sex, n, male/female = 23/51. MMSE, Mini-Mental State Examination; PK, phylloquinone.
FIGURE 1Hierarchical Ward-linkage clustering based on the Spearman correlation coefficients of the abundance of vitamin K genes for the 74 samples. Clusters are indicated by a color bar along the top of the heatmap and sample names along the rows and columns.
FIGURE 2Principal coordinates analysis based on reads aligned to the vitamin K abundance matrix (VKAM), which shows the multivariate spread and variation of the VKAM across the subjects with significant differences observed across the 4 clusters (P ≤ 0.001, Adonis test). The first principal component (PC1) explains over 10% of the data set variation while the second PC explains 7%. Cluster 1 contained 11 subjects (15% of the samples), cluster 2 comprised 19 subjects (26%), cluster 3 had 29 subjects (39%), and cluster 4 contained 15 subjects (20%).
FIGURE 3Distribution of samples’ coordinates along principal coordinates analysis (PCoA) axis 1 based on the menaquinone biosynthesis genes and Mini-Mental State Examination (MMSE) score differences across the 4 vitamin K abundance clusters. (A) Boxplots represent the distribution of samples’ coordinates, within each cluster, along the PCoA axis 1. Cluster 1 comprised 11 subjects, cluster 2 had 19 subjects, cluster 3 contained 29 subjects, and cluster 4 had 15 subjects. (B) Boxplots of the distribution of MMSE scores for the 74 samples, organized by vitamin K clusters. Cluster 1 comprised 11 subjects, cluster 2 had 19 subjects, cluster 3 contained 29 subjects, and cluster 4 had 15 subjects. Boxplots represent a 5-point summary of the data in the following order (from bottom to top): minimum, first quartile, median, third quartile, and maximum. P values were calculated by Kruskal-Wallis tests with post hoc Dunn test using Benjamini-Hochberg correction. *P < 0.05. **P < 0.01. ***P < 0.001. ****P < 0.0001.
Characteristics of the study's participants organized by vitamin K abundance clusters[1]
| Mean ± SD | Cluster vs. cluster | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Characteristic | Cluster 1 ( | Cluster 2 ( | Cluster 3 ( | Cluster 4 ( |
| 1 vs. 2 | 1 vs. 3 | 1 vs. 4 | 2 vs. 3 | 2 vs. 4 | 3 vs. 4 |
| MMSE score | 15 ± 9.7 | 23 ± 7.5 | 27 ± 4.6 | 26 ± 4 | 0.001[ | 0.035[ | <0.001[ | 0.001[ | 0.032[ | 0.123 | 0.272 |
| Age, y | 85 ± 7.4 | 80 ± 9.6 | 76 ± 8.3 | 75 ± 6.8 | 0.019[ | 0.121 | 0.015[ | 0.010[ | 0.100 | 0.118 | 0.400 |
| Barthel score | 8.3 ± 6.5 | 14.7 ± 7.1 | 17.4 ± 4.9 | 18.5 ± 3.6 | <0.001[ | 0.025 [ | <0.001[ | 0.042[ | <0.001[ | 0.039[ | 0.323 |
| No. of hypertension medications | 0.18 ± 0.4 | 0.53 ± 0.9 | 0.45 ± 0.9 | 0.27 ± 0.6 | 0.759 | 1.000 | 0.508 | 0.433 | 0.471 | 0.594 | 0.480 |
| No. of diabetes medications | 0 ± 0 | 0.21 ± 0.5 | 0.07 ± 0.3 | 0 ± 0 | <0.001[ | 0.105 | 0.396 | 0.500 | 0.071[ | 0.140 | 0.469 |
| No. of diagnoses | 5.9 ± 2.9 | 3.7 ± 2 | 2.2 ± 1.8 | 2.8 ± 2 | 0.001[ | 0.090 | 0.001[ | 0.012[ | 0.014[ | 0.112 | 0.188 |
| No. of drugs | 6.3 ± 3.2 | 4.7 ± 2.9 | 4.8 ± 3.6 | 4.8 ± 1.9 | 0.339 | 0.199 | 0.220 | 0.413 | 0.221 | 0.485 | 0.480 |
| Serum PK, nmol/L | 0.82 ± 08 | 0.86 ± 0.8 | 1.18 ± 1.5 | 0.73 ± 0.5 | 0.04[ | 0.582 | 0.347 | 0.489 | 0.720 | 0.706 | 0.468 |
| TNF-α, IU | 7.89 ± 3.7 | 9.97 ± 12.5 | 4.79 ± 1.9 | 5.64 ± 2.8 | 0.033[ | 0.177 | 0.018[ | 0.083 | 0.091 | 0.240 | 0.191 |
| IL-6, IU | 13.13 ± 12.7 | 28.08 ± 51.1 | 5.96 ± 3.5 | 17.67 ± 42.8 | 0.025[ | 0.351 | 0.101 | 0.221 | 0.013[ | 0.087 | 0.252 |
| IL-8, IU | 25.56 ± 17.5 | 18.59 ± 8.4 | 20.38 ± 26.4 | 14.42 ± 7.8 | 0.198 | 0.2392 | 0.2003 | 0.1318 | 0.2237 | 0.1486 | 0.2878 |
| Diversity: Shannon index | 3.04 ± 0.4 | 3.53 ± 0.3 | 3.79 ± 0.5 | 3.55 ± 0.6 | 0.001[ | 0.017[ | <0.001[ | 0.018[ | 0.051[ | 0.499 | 0.058 |
| BMI, kg/m2 | 23.7 ± 5.8 | 27 ± 4.5 | 26.5 ± 5.8 | 29.8 ± 8.8 | 0.123 | 0.047 | 0.083 | 0.290 | 0.091 | 0.439 | 0.316 |
Values are means ± SD. Individual values can be found in Supplemental Table 7. MMSE, Mini-Mental State Examination; PK, phylloquinone.
P < 0.05, Dunn post hoc test for pairwise comparisons.
P < 0.05, Kruskal-Wallis test.
Categorical characteristics of the study's participants organized by vitamin K abundance clusters[1]
| Number | Cluster vs. cluster | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Characteristic | Cluster 1 ( | Cluster 2 ( | Cluster 3 ( | Cluster 4 ( |
| 1 vs. 2 | 1 vs. 3 | 1 vs. 4 | 2 vs. 3 | 2 vs. 4 | 3 vs. 4 |
| Sex, | 0.963 | 1 | 1 | 0.920 | 1 | 1 | 1 | ||||
| Male/female | 4/7 | 6/13 | 9/20 | 4/11 | |||||||
| Strata, | 0.013[ | 0.155 | 0.020[ | 0.006[ | 0.463 | 0.155 | 0.463 | ||||
| Long stay | 7 | 6 | 4 | 0 | |||||||
| Rehabilitation | 2 | 1 | 3 | 1 | |||||||
| Day hospital | 0 | 3 | 4 | 2 | |||||||
| Community | 2 | 9 | 18 | 12 | |||||||
| Hypertension, | 0.359 | 0.973 | 1 | 1 | 0.973 | 0.973 | 1 | ||||
| Presence/absence | 3/8 | 9/10 | 7/22 | 4/11 | |||||||
| Diabetes, | 0.036[ | 0.562 | 1 | 1 | 0.525 | 0.525 | 1 | ||||
| Presence/absence | 0/11 | 4/15 | 1/28 | 0/15 | |||||||
| Antipsychotic medications, | 0.094 | 0.275 | 0.275 | 0.423 | 1 | 1 | 1 | ||||
| Presence/absence | 6/4 | 4/15 | 6/23 | 4/11 | |||||||
Values are numbers for each variable detailing the categorical characteristics of n = 74 elderly samples. Individual values can be found in Supplemental Table 7.
P < 0.05 Benjamini-Hochberg for multiple corrections.
P < 0.05 χ2 test.
Association of each variable in the Poisson statistical model with MMSE[1]
| Variable | eRC | 2.5%, 97.5% CI |
|
|---|---|---|---|
| Age, y | 1 | 0.98, 1.02 | 0.98 |
| Cluster 2 ( | 0.58 | 0.38, 0.89 | 0.013[ |
| Cluster 3 ( | 0.54 | 0.33, 0.89 | 0.017[ |
| Cluster 4 ( | 0.83 | 0.51, 1.37 | 0.47 |
| Strata (day hospital) ( | 1.32 | 0.59, 2.77 | 0.48 |
| Strata (long stay) ( | 3.38 | 1.51, 7.55 | 0.003[ |
| Strata (rehab) ( | 3.15 | 1.59, 6.26 | <0.001[ |
| Gender (male) ( | 0.89 | 0.62, 1.27 | 0.52 |
| Barthel score | 0.98 | 0.93, 1.03 | 0.49 |
| No. of diagnoses | 0.91 | 0.83, 1 | 0.049[ |
| No. of drugs | 0.98 | 0.91, 1.05 | 0.48 |
| Presence of hypertension ( | 0.87 | 0.54, 1.38 | 0.58 |
| Hypertension, 1 medication ( | 0.83 | 0.47, 1.47 | 0.52 |
| Hypertension, 2 medications, ( | 1.55 | 0.69, 3.42 | 0.28 |
| Hypertension, 3 medications, ( | 0.55 | 0.08, 2.07 | 0.45 |
| Presence of diabetes ( | 4.17 | 0.58, 32.46 | 0.16 |
| Diabetes, 1 medication ( | 0.26 | 0.03, 2.02 | 0.21 |
| Diabetes, 2 medications ( | 0.31 | 0.03, 3.26 | 0.33 |
| Serum PK, nmol/L | 0.93 | 0.65, 1.25 | 0.64 |
| TNF-α, IU | 0.99 | 0.95, 1.04 | 0.73 |
| IL-6, IU | 1.01 | 1, 1.01 | 0.055 |
| IL-8, IU | 1 | 0.99, 1 | 0.61 |
| Diversity: Shannon index | 0.74 | 0.5, 1.11 | 0.14 |
| BMI, kg/m2 | 0.99 | 0.95, 1.02 | 0.4 |
| Antidepressants/antipsychotics ( | 1.52 | 0.97, 2.38 | 0.066 |
Association between the vitamin K clusters and MMSE after adjusting for age; Barthel score; presence of hypertension and diabetes; number of cardiovascular and diabetes medications; polypharmacy; multimorbidity; concentrations of serum PK, TNF-α, IL-6, and IL-8; Shannon diversity; BMI; antipsychotic medications; gender; and strata. eRC, exponentiated regression coefficient; MMSE, Mini-Mental State Examination; PK, phylloquinone.
P < 0.05, Poisson regression model.
Results of Kruskal-Wallis tests to assess differences across the clusters for each of the MK chains[1]
| Cluster vs. cluster | ||||||||
|---|---|---|---|---|---|---|---|---|
| Characteristic |
| BH-adjusted | 1 vs. 2 | 1 vs. 3 | 1 vs. 4 | 2 vs. 3 | 2 vs. 4 | 3 vs. 4 |
| MK4 | 0.610 | 0.610 | 0.466 | 0.639 | 0.438 | 0.417 | 0.371 | 0.465 |
| MK5 | <0.001[ | <0.001[ | 0.016[ | 0.003[ | 0.293 | 0.324 | 0.002[ | <0.001[ |
| MK6 | 0.074 | 0.102 | 0.039 | 0.059 | 0.157 | 0.487 | 0.176 | 0.209 |
| MK7 | 0.289 | 0.317 | 0.440 | 0.271 | 0.298 | 0.172 | 0.319 | 0.391 |
| MK8 | <0.001[ | <0.001[ | 0.389 | 0.011[ | <0.001[ | 0.001[ | <0.001[ | 0.009[ |
| MK9 | <0.001[ | <0.001[ | 0.464 | 0.010[ | <0.001[ | 0.001[ | <0.001[ | 0.017[ |
| MK10 | 0.001[ | 0.001[ | 0.191 | 0.068 | 0.001[ | 0.215 | 0.002[ | 0.007[ |
| MK11 | <0.001[ | 0.001[ | 0.328 | 0.271 | 0.012[ | 0.349 | 0.001[ | <0.001[ |
| MK12 | <0.001[ | 0.001[ | 0.110 | 0.002[ | 0.429 | 0.035[ | 0.091 | 0.001[ |
| MK13 | <0.001[ | 0.001[ | 0.062 | <0.001[ | 0.199 | 0.015[ | 0.207 | 0.003[ |
| PK | 0.182 | 0.222 | 0.174 | 0.094 | 0.260 | 0.328 | 0.327 | 0.223 |
Results of assessing the independence of MK chain concentration across the clusters. Cluster 1, n = 11; cluster 2, n = 19; cluster 3, n = 29; cluster 4, n = 15. Individual MK and PK values are listed in Supplemental Tables 3 and 7, respectively. BH, Benjamini-Hochberg; MK, menaquinone; PK, phylloquinone.
P < 0.05, Dunn post hoc test for pairwise comparisons, adjusted by the BH method.
P < 0.05, Kruskal-Wallis test.
P < 0.05, Kruskal-Wallis test adjusted using BH correction.
Poisson regression model examining the association of MK chains and MMSE[1]
| MK chain | eRC | 2.5, 97.5% CI |
|
|---|---|---|---|
| MK4 | 1.1 | 1.04, 1.17 | 0.001[ |
| MK5 | 1.31 | 0.61, 2.73 | 0.48 |
| MK6 | 0.85 | 0.75, 0.94 | 0.003[ |
| MK7 | 1.01 | 0.96, 1.06 | 0.72 |
| MK8 | 1.01 | 1, 1.02 | <0.001[ |
| MK9 | 1.21 | 1.14, 1.28 | <0.001[ |
| MK10 | 1.06 | 1.03, 1.08 | <0.001[ |
| MK11 | 1 | 0.97, 1.03 | 0.92 |
| MK12 | 0.98 | 0.96, 0.99 | 0.009[ |
| MK13 | 0.99 | 0.98, 1 | 0.014[ |
Association between each MK isoform and Mini-Mental State Examination after adjusting for the clusters inferred from all confounding factors. Only MK variables are shown. eRC, exponentiated regression coefficient; MK, menaquinone.
P < 0.05; Poisson regression model.
Results of Kruskal-Wallis examining the spread of the pathway steps across the clusters[1]
| Steps |
| BH-adjusted |
|---|---|---|
| Futalosine | 0.146 | 0.245 |
| MenF | 0.065 | 0.163 |
| MenD | 0.041[ | 0.138 |
| MenH | 0.007[ | 0.075 |
| MenC | 0.023[ | 0.119 |
| MenE | 0.112 | 0.226 |
| MenB | 0.252 | 0.361 |
| MenI | 0.319 | 0.399 |
| MenA | 0.783 | 0.871 |
| MenG | 0.872 | 0.873 |
Examining the spread of the menaquinone biosynthesis pathway genes across the clusters. Cluster 1, n = 11; cluster 2, n = 19; cluster, 3 n = 29; cluster 4, n = 15. Kruskal-Wallis test adjusted using BH correction. Individual counts for each of the steps are listed in Supplemental Table 11. BH, Benjamini-Hochberg.
P < 0.05, Kruskal-Wallis test.
Association of each step of the vitamin K pathway and MMSE[1]
| Step | eRC | 2.5, 97.5% CI |
|
|---|---|---|---|
| Futalosine | 1 | 0.9998, 1.0001 | 0.63 |
| MenF | 0.9999 | 0.9998, 1 | 0.003[ |
| MenD | 1 | 0.9999, 1 | 0.26 |
| MenH | 0.9997 | 0.9993, 1.0001 | 0.12 |
| MenC | 0.9998 | 0.9995, 1.0001 | 0.21 |
| MenE | 1 | 1, 1 | 0.7 |
| MenB | 0.9999 | 0.9998, 1 | 0.076 |
| MenI | 1.0336 | 1.0151, 1.0512 | <0.001[ |
| MenA | 1 | 0.9999, 1.0001 | 0.96 |
| MenG | 1.0001 | 1, 1.0002 | 0.16 |
Associations between steps of the vitamin K pathway and MMSE errors after adjusting for clusters of confounding factors for n = 74 samples. eRC, exponentiated regression coefficient; MMSE, Mini-Mental State Examination.
P < 0.05, Poisson regression model.